Cyclohexane-fused octahydroquinolizine alkaloids from Myrioneuron faberi with activity against hepatitis C virus

Journal of Organic Chemistry

Volumn 79, Issue 17, 2014, Pages 7945-7950

  Cao, Ming Ming ^a,b   Zhang, Yu ^a   Li, Xiao Hui ^a,b   Peng, Zong Gen ^c   Jiang, Jian Dong ^c   Gu, Yu Cheng ^d   Di, Ying Tong ^a   Li, Xiao Nian ^a   Chen, Duo Zhi ^a   Xia, Cheng Feng ^a   He, Hong Ping ^a   Li, Shun Lin ^a   Hao, Xiao Jiang ^e  

^a KUNMING INSTITUTE OF BOTANY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^d JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOIDS; CYCLOHEXANE; METABOLITES; NITROGEN COMPOUNDS; VIRUSES; X RAY DIFFRACTION;

ANOMERS; EPIMERS; HEPATITIS C VIRUS; IN-VITRO; NMR ANALYSIS; QUINOLIZIDINE ALKALOIDS;

CHEMICAL COMPOUNDS;

13ALPHA METHOXY MYRIFABRAL A; 13BETA METHOXY MYRIFABRAL A; ALKALOID DERIVATIVE; ALPHA MYRIFABRAL A; ANTIVIRUS AGENT; BETA MYRIFABRAL A; CYCLOHEXANE; DECAHYDROQUINOLINE DERIVATIVE; QUINOLIZINE DERIVATIVE; TELAPREVIR; UNCLASSIFIED DRUG; ALKALOID; CYCLOHEXANE DERIVATIVE; FUSED HETEROCYCLIC RINGS; MYRIBERINE A;

ANTIVIRAL ACTIVITY; ARTICLE; CHINA; CHINESE HERB; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; ENANTIOMER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; MYRIONEURON FABERI; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; VIRUS REPLICATION; X RAY DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HEPACIVIRUS; ISOLATION AND PURIFICATION; STEREOISOMERISM; X RAY CRYSTALLOGRAPHY;

ALKALOIDS; ANTIVIRAL AGENTS; CRYSTALLOGRAPHY, X-RAY; CYCLOHEXANES; HEPACIVIRUS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; QUINOLIZINES; STEREOISOMERISM;

EID: 84910101504     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo501076x     Document Type: Article

References (34)

1. WHO. Hepatitis C. Fact sheet No. 164 2014; www.who.int/mediacentre/factsheets/fs164/en/ (updated April 2014).
2. Zeuzem, S. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5, 610-622
3. McHutchison, J. G.; Lawitz, E. J.; Shiffman, M. L.; Muir, A. J.; Galler, G. W. N. Engl. J. Med. 2009, 361, 580-593
4. Thompson, A. J.; McHutchison, J. G. J. Viral Hepat. 2009, 16, 377-387
5. Afdhal, N. H.; Zeuzem, S.; Schooley, R. T.; Thomas, D. L.; Ward, J. W.; Litwin, A. H.; Razavi, H.; Castera, L.; Poynard, T.; Muir, A.; Mehta, S. H.; Dee, L.; Graham, C.; Church, D. R.; Talal, A. H.; Sulkowski, M. S.; Jacobson, I. M. J. Viral Hepat. 2013, 20, 745-760
6. Ghany, M. G.; Strader, D. B.; Thomas, D. L.; Seeff, L. B. Hepatology 2009, 49, 1335-1374
7. Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2012, 75, 311-335
8. Pham, V. C.; Jossang, A.; Chiaroni, A.; Sévenet, T.; Bodo, B. Tetrahedron Lett. 2002, 43, 7565-7568
9. Pham, V. C.; Jossang, A.; Chiaroni, A.; Sévenet, T.; Nguyen, V. H.; Bodo, B. Org. Lett. 2007, 9, 3531-3534
10. Pham, V. C.; Jossang, A.; Grellier, P.; Chiaroni, A.; Sévenet, T.; Nguyen, V. H.; Bodo, B. J. Org. Chem. 2008, 73, 7565-7573
11. Pham, V. C.; Jossang, A.; Sévenet, T.; Nguyen, V. H.; Bodo, B. Eur. J. Org. Chem. 2009, 74, 1412-1416
12. Pham, V. C.; Jossang, A.; Sévenet, T.; Nguyen, V. H.; Bodo, B. Tetrahedron 2007, 63, 11244-11249
13. Huang, S.-D.; Zhang, Y.; Cao, M.-M.; Di, Y.-T.; Tang, G.-H.; Peng, Z.-G.; Jiang, J.-D.; He, H.-P.; Hao, X.-J. Org. Lett. 2013, 15, 590-593
14. Cao, M.-M.; Huang, S.-D.; Di, Y.-T.; Yuan, C.-M.; Zuo, G.-Y.; Gu, Y.-C.; Zhang, Y.; Hao, X.-J. Org. Lett. 2014, 16, 528-531
15. Luo, X.-R.; Gao, Y.-Z.; Chen, W.-Q.; Xu, X.-H.; Wu, H. Flora of China 1999, 71, 310-312
16. Pathak, A. K.; Jain, D. C.; Sharma, R. P. Indian J. Chem. B 1995, 11, 992-993
17. Bates, R. B.; Haber, W. A.; Setzer, W. N.; Stessman, C. C. J. Nat. Prod. 1999, 62, 340-341
18. Kwon, Y.-J.; Sohn, M.-J.; Kim, C.-J.; Koshino, H.; Kim, W.-G. J. Nat. Prod. 2012, 75, 271-274
19. Chen, X.-M.; Cai, J.-W. In The Principle and Practice of Single Crystal Sructure Analysis; Science Press: Beijing, 2003; pp 23-36.
20. Wu, H.-K.; Fronczek, F. R.; Ferreira, D.; Burandt, C. L., Jr; Zjawiony, J. K. J. Nat. Prod. 2011, 74, 831-836
21. Miller, K. A.; Tsukamoto, S.; Williams, R. M. Nat. Chem. 2009, 1, 63-68
22. Finefield, J. M.; Sherman, D. H.; Kreitman, M.; Williams, R. M. Angew. Chem., Int. Ed. 2012, 51, 4802-4836
23. Michael, J. P. Nat. Prod. Rep. 2008, 25, 139-165
24. Wanner, M. J.; Koomen, G. J. Pharmacochem. Libr. 1997, 28, 179-187
25. Golebiewski, W. M.; Spenser, I. D. J. Am. Chem. Soc. 1976, 98, 6726-6728
26. Gravel, E.; Harfouche, A.; Salame, R.; Leblanc, K.; Maciuk, A.; Poupon, E. Chem. Eur. J. 2013, 19, 14515-14520
27. Gravel, E.; Poupon, E.; Hocquemiller, R. Org. Lett. 2005, 7, 2497-2499
28. Francois, D.; Lallemand, M.-C.; Selkti, M.; Tomas, A.; Kunesch, N.; Husson, H.-P. Angew. Chem., Int. Ed. 1998, 37, 104-105
29. Wanner, M. J.; Koomen, G.-J. J. Org. Chem. 1995, 60, 5634-5637
30. The formaldehyde may result from microbial degradation reactions: Dewick, P. M. In Medicinal Natural Products: A Biosynthetic Approach, 3 rd ed.; Wiley: Chichester, U.K., 2009; pp 163-165.
31. Livak, K. J.; Schmittgen, T. D. Methods 2001, 25, 402-4-8
32. Reed, L. J.; Muench, H. A. Am. J. Hyg. 1938, 27, 493-497
33. Peng, Z.-G.; Fan, B.; Du, N.-N.; Wang, Y.-P.; Gao, L.-M.; Li, Y.-H.; You, X.-F.; Han, Y.-X.; Zhao, Z.-Y.; Cen, S.; Li, J.-R.; Song, D.-Q.; Jiang, J.-D. Hepatology 2010, 52, 845-853
34. Sheldrick, G. M. SHELXL97; University of Göttingen, Göttingen, Germany, 1997.